Agendia Expands its Business Activities in Germany

10-26-2016

The “BRIDGE” initiative offers German patients free access to Agendia’s MammaPrint® breast cancer recurrence assay Data from the MINDACT trial shows MammaPrint is the only test on the German market supported by the highest level of medical evidence (1A) IRVINE, … Continued